Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756806 · ClinicalTrials.gov registry record · NA
A Clinical Evaluation for Tattoo Removal
A NA study, sponsored by Cutera.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02756806: Clinical Trial NA study, sponsored by Cutera.
NCT02756806 is a NA study that was terminated before completion, run by Cutera. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02756806, a NA study, was terminated before completion, sponsored by Cutera.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Evaluate safety and efficacy with the enlighten laser for tattoo removal.
Primary Outcome
Degree of tattoo clearing at 12 weeks post-final treatment as assessed by independent blinded reviewers (Physician's Global Assessment of Improvement). Min=0; Max=4 Higher score indicate better tattoo clearing 4= Very Significant Clearing (\>75%) 3 = Significant Clearing (51-75%) 2 = Moderate Clearing (26-50%) 1 = Mild Clearing (5-25%) 0 = No Change (\<5%)
Interventions
- DEVICE Picosecond Q-switched laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-09-28 |
| Phase | NA |
Why NCT02756806 stopped before completion
NCT02756806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Picosecond Q-switched laser is the first listed.
NCT02756806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02756806 about?
NCT02756806 is a clinical study titled "A Clinical Evaluation for Tattoo Removal". Evaluate safety and efficacy with the enlighten laser for tattoo removal.
What is the current status of trial NCT02756806?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2016-04. Estimated completion is 2016-09-28.
What interventions are being tested in trial NCT02756806?
The interventions under investigation include: Picosecond Q-switched laser (DEVICE).
Who is sponsoring clinical trial NCT02756806?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02756806's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia